Sugrue M F, Shaw G, Charlton K G
Eur J Pharmacol. 1977 Apr 21;42(4):379-85. doi: 10.1016/0014-2999(77)90172-8.
Mazindol was devoid of effect both on rat brain steady state levels of 5-HT, 5-HIAA and tryptophan and on the rate of synthesis of 5-HT in the rat brain. Mazindol had no effect on rat brain 5-HT uptake in vivo as determined by the effect of drug pretreatment on the ability of p-chloroamphetamine to lower central 5-HT levels. A large dose of mazindol caused a slight transient decrease in rat brain levels of NA and DA. Blockade of rat brain catecholamine uptake was quantified by studying drug effects on the ability of intraventricularly administered 6-hydroxydopamine to lower brain NA and DA content. Mazindol was an extremely potent inhibitor of rat brain NA uptake in vivo, being 4-5 times more potent than desipramine. Mazindol also blocked rat brain DA uptake. Doses of mazindol needed to release alpha-methyl-m-tyramine from the rat striatum were appreciably greater than the corresponding doses of d-amphetamine. The neurochemical profile of mazindol bears a much closer resemblance to that of d-amphetamine than to that of fenfluramine.
马吲哚对大鼠脑内5-羟色胺(5-HT)、5-羟吲哚乙酸(5-HIAA)和色氨酸的稳态水平以及大鼠脑内5-HT的合成速率均无影响。通过药物预处理对对氯苯丙胺降低中枢5-HT水平能力的影响来确定,马吲哚对大鼠脑内5-HT的体内摄取没有影响。大剂量的马吲哚导致大鼠脑内去甲肾上腺素(NA)和多巴胺(DA)水平出现轻微的短暂下降。通过研究药物对脑室内注射6-羟基多巴胺降低脑内NA和DA含量能力的影响,对大鼠脑内儿茶酚胺摄取的阻断作用进行了量化。马吲哚是大鼠脑内NA体内摄取的一种极其有效的抑制剂,其效力比地昔帕明强4至5倍。马吲哚也阻断大鼠脑内DA的摄取。从大鼠纹状体释放α-甲基间酪氨酸所需的马吲哚剂量明显大于相应剂量的右旋苯丙胺。与芬氟拉明相比,马吲哚的神经化学特征与右旋苯丙胺更为相似。